IMAGE

Fig. 2

ID
ZDB-IMAGE-071204-18
Source
Figures for Li et al., 2007
Image
Figure Caption

Fig. 2 tfap2a mutant embryos injected with tfap2c morpholino (MO) display abnormal development in ectoderm-derived tissues. (A) Top, schematic of the tfap2c gene showing the position of MOs used in this study; middle, effects of the tfap2c e3i3 MO on the tfap2c transcript; bottom, the Tfap2c protein. Roman numerals refer to exons, numbers refer to amino acids. TA, transactivation domain. DBD, DNA binding domain. e3i3 MO targeting the exon 3 splice donor site and i3e4 MO targeting the exon 4 splicing acceptor site are shown in red. P1 and P2 are the primers used for the RT-PCR shown in panel B. tfap2c e3i3 MO causes a deletion of 38 nucleotides, which leads to a frame shift and introduces a stop codon at the end of exon 3. (B) tfap2c RT-PCR results. Amplification of cDNA from uninjected wild-type embryos (wt) with the primers P1 and P2 shown in panel A yielded a single band of the expected size of 557 bp, while amplification of 24 hpf cDNA from tfap2c e3i3 MO injected embryos (e3i3 MO) yielded a smaller band of 519 bp. Amplification of cDNA from tfap2c i3e4 MO injected embryos (i3e4 MO) also yielded a smaller band. M, 100 bp ladder. (C–F) Lateral views of live embryos at 28 hpf. In panel C, a wild-type embryo injected with standard control MO (hereafter, control embryo) with normal morphology and pigmentation. In panel D, a control MO-injected tfap2a homozygous mutant embryo displaying normal morphology but reduced number of melanophores. In panel E, a wild-type embryo injected with tfap2c e3i3 MO with normal morphology and pigmentation. (F) A tfap2a homozygous mutant embryo injected with tfap2c e3i3 MO (hereafter, tfap2a-/cMO embryo), with no visible pigmentation, an absence of yolk extension, a poorly extended tail, and edema ventral to the hindbrain (asterisk). (G–L) Lateral views of the embryos shown in panels C and F at higher magnification. Olfactory placode (arrowhead in panel G) and lens (arrowhead in panel I) are visible in the control embryo but not in the tfap2a-/cMO embryo (H, J) which also displays malformation of the ventral retina. Otic vesicle in panel K, the control embryo, contains two otoliths (arrowhead). While in panel L, the tfap2a-/cMO embryo, it is reduced in size and contains a single otolith (arrowhead). An enlarged view of the edema ventral to the hindbrain is also seen (asterisk). (M, N) Lateral views of the same embryos shown in panels C and F at 72 hpf. Medial fin folds, as outlined in panel M, the control embryo, are virtually absent in panel N, the tfap2a-/cMO embryo. Notochord and somites also appear abnormal, presumably due to indirect effects, because tfap2a and tfap2c expression are not detected in these tissues. Scale bars: 100 μm.

Figure Data
Acknowledgments
This image is the copyrighted work of the attributed author or publisher, and ZFIN has permission only to display this image to its users. Additional permissions should be obtained from the applicable author or publisher of the image.

Reprinted from Developmental Biology, 304(1), Li, W., and Cornell, R.A., Redundant activities of Tfap2a and Tfap2c are required for neural crest induction and development of other non-neural ectoderm derivatives in zebrafish embryos, 338-354, Copyright (2007) with permission from Elsevier. Full text @ Dev. Biol.